A Phase I Clinical Study to Evaluate SM17 in Chinese Healthy Subjects and Patients With Moderate to Severe Atopic Dermatitis
Clinical trial NCT07103369 · COMPLETED
Trial details
- NCT number
- NCT07103369
- Sponsor
- SinoMab BioScience Ltd
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2023-11-21
- Primary completion
- 2025-03-24
- Enrollment
- 64
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.